Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 6/20 | 0.96 |
| ▸ | CA1 | P00915 | 6/20 | 0.96 |
| ▸ | CA2 | P00918 | 6/20 | 0.96 |
| ▸ | CA7 | P43166 | 6/20 | 0.96 |
| ▸ | CA9 | Q16790 | 6/20 | 0.96 |
| ▸ | CA14 | Q9ULX7 | 6/20 | 0.96 |
| ▸ | ESR1 | P03372 | 3/20 | 0.96 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.96 |
| ▸ | TSHR | P16473 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.69 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.69 |
| ▸ | KDR | P35968 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | MAOA | P21397 | 1/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylparaben SCHEMBL27833843 | 0.98 | CA12 (0.92) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL5311680 | 0.98 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL28368 | 0.98 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL29290346 | 0.96 | CA12 (0.96) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL29358972 | 0.96 | CA12 (0.96) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL23497074 | 0.96 | CA12 (0.96) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL29374744 | 0.96 | CA12 (0.96) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL31347872 | 0.96 | CA12 (0.96) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL475792 | 0.96 | CA12 (0.96) | CA12CA1CA2CA7CA9 | |
| Ethylparaben SCHEMBL31655760 | 0.96 | CA12 (0.96) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 376 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608929-A1 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LyondellBasell Advanced Polymers Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| US-12338390-B2 | Bridging particle and fluid loss control agent | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2025-06-24 | — | — | US | claimed |
| US-20240228859-A9 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2024-07-11 | — | — | US | claimed |
| WO-2024091462-A1 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2024-05-02 | — | — | WO | claimed |
| US-20240132772-A1 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2024-04-25 | — | — | US | claimed |
| CN-107635589-A | Essentially antimicrobial porous matrix composites and methods of making the same | 约翰·保罗·威尔逊 | 2018-01-26 | — | — | CN | claimed |
| US-7128923-B2 | Preserved and stable compositions containing peptide copper complexes and method related thereto | PROCYTE CORPORATION (US) | 2006-10-31 | — | — | US | claimed |
| EP-4724590-A1 | ADENO-ASSOCIATED VIRUS FORMULATIONS | 4D Molecular Therapeutics Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-3592329-B1 | USE OF COMPATIBLE SOLUTES | SUSONITY Commercial GmbH (DE) | 2026-02-18 | — | — | EP | disclosed |
| US-12553062-B2 | AAV compositions | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2026-02-17 | — | — | US | disclosed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| US-12545860-B2 | Mannanase variants | BASF SE (DE) | 2026-02-10 | — | — | US | disclosed |
| US-20260034042-A1 | Composition with Improved SPF and UVA Photoprotection | SYMRISE AG (DE) | 2026-02-05 | — | — | US | disclosed |
| US-20040247655-A1 | Adhesive compositions, articles incorporating same and methods of manufacture | 3M INNOVATIVE PROPERTIES COMPANY | 2004-12-09 | — | — | US | disclosed |
| US-6821568-B2 | THE INTERFACE BETWEEN A MOVING CONVEYOR BELT AND A WORK PIECE CAN BE LUBRICATED USING AN AIR DRIVEN STREAM OF FINELY DIVIDED DROPLETS OF A LUBRICANT COMPOSITION. DROPLETS OF A PREFERRED SIZE ARE DIRECTED BY THE AIR STREAM ONTO THE CONVEYOR WITH | ECOLAB INC. | 2004-11-23 | — | — | US | disclosed |
| US-20030207040-A1 | Lubricant qualified for contact with a composition suitable for human consumption including a food, a conveyor lubrication method and an apparatus using droplets or a spray of liquid lubricant | ECOLAB INC. | 2003-11-06 | — | — | US | disclosed |
| US-6576298-B2 | For use in container filling or packaging operations for foods (frozen), beverages | ECOLAB INC. | 2003-06-10 | — | — | US | disclosed |
| US-20020115573-A1 | Lubricants formulated and qualified for contact with food compositions and related business methods | ECOLAB USA INC. | 2002-08-22 | — | — | US | disclosed |
| US-20020051850-A1 | Lubricant qualified for contact with a composition suitable for human consumption including a food, a conveyor lubrication method and an apparatus using droplets or a spray of liquid lubricant | ECOLAB USA INC. | 2002-05-02 | — | — | US | disclosed |
| WO-2002020380-A1 | A LUBRICANT QUALIFIED FOR CONTACT WITH A COMPOSITION SUITABLE FOR HUMAN CONSUMPTION, A CONVEYOR LUBRICATION METHOD AND APPARATUS | ECOLAB INC. (US) | 2002-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | CA12 4850/4885CA1 4875/4885CA2 4525/4885 |
| US-12545860-B2 | Mannanase variants | MAN2A1, MANBA, IDUA | CA12 3172/4885CA1 4163/4885CA2 4162/4885 |
| US-12553062-B2 | AAV compositions | PRDM9, H1-10, SLC20A1 | CA12 544/4885CA1 495/4885CA2 2353/4885 |
| US-20260034042-A1 | Composition with Improved SPF and UVA Photoprotection | TYR, ERG28, CUTA | CA12 4826/4885CA1 4868/4885CA2 4757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.